[ Price : $8.95]
Ultragenyx Pharmaceutical says an IND application for UX007, a treatment for long-chain fatty acid oxidation disorders is active a...[ Price : $8.95]
Federal Register Notice: FDA makes available on its Web site revised final versions of four documents that support making electron...[ Price : $8.95]
Federal Register Notice: FDA submits a proposed collection of information on ANADA applications to the Office of Management and Bu...[ Price : $8.95]
Federal Register Notice: FDA seeks comments on submitting information on dietary supplements or new dietary ingredients and a conc...[ Price : $8.95]
Federal Register Notice: FDA releases a revised draft guidance that provides specific recommendations for the design of bioequival...[ Price : $8.95]
FDA delays until 6/2014 its implementation date for new recommendations in a recently released ANDA stability data guidance.[ Price : $8.95]
FDA releases a bioequivalence guidance for generic copies of Janssens atypical antipsychotic Risperdal (risperidone).[ Price : $8.95]
A product liability plaintiff moves to the FDA citizen petition process to seek an investigation of adverse events and false adver...